rs143303485
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_144991.3(TSPEAR):c.1185G>T(p.Glu395Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152166Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000636 AC: 16AN: 251460 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727206 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74462 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Reported in a patient with suspected Pendred syndrome in published literature (Nonose et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29739340) -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 504871). This variant has not been reported in the literature in individuals affected with TSPEAR-related conditions. This variant is present in population databases (rs143303485, gnomAD 0.08%). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 395 of the TSPEAR protein (p.Glu395Asp). -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Glu395Asp var iant in TSPEAR has not been previously reported in individuals with hearing loss , but was identified in 0.1% (19/24032) of African chromosomes by the Genome Agg regation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs143303485). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Glutamic acid (Glu) at position 395 is not conserved in mammals or evolutionarily distant species and >10 specie s carry a aspartic acid (Asp) at this position, raising the possibility that thi s change may be tolerated. Additional computational prediction tools support tha t the variant may not impact the protein, though this information is not predict ive enough to rule out pathogenicity. In summary, while the clinical significanc e of the p.Glu395Asp variant is uncertain, these data suggest that it is more li kely to be benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at